PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
188.35%
Revenue growth exceeding 1.5x Insurance - Life median of 5.17%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
188.35%
Gross profit growth exceeding 1.5x Insurance - Life median of 4.09%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
292.51%
EBIT growth exceeding 1.5x Insurance - Life median of 3.46%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
292.51%
Operating income growth exceeding 1.5x Insurance - Life median of 9.15%. Joel Greenblatt would see if unique processes drive exceptional profitability.
606.54%
Net income growth exceeding 1.5x Insurance - Life median of 12.52%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
606.13%
EPS growth exceeding 1.5x Insurance - Life median of 11.94%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
606.90%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 12.18%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.42%
Negative OCF growth while Insurance - Life median is -17.42%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-17.42%
Negative FCF growth while Insurance - Life median is -17.42%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
189.36%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 43.20%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
66.45%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 33.04%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
8.49%
3Y revenue/share growth 50-75% of Insurance - Life median of 14.48%. Guy Spier might worry about a waning short-term advantage.
55.01%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 16.16% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
137.90%
OCF/share CAGR of 137.90% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
44.80%
3Y OCF/share growth of 44.80% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
302.43%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 102.33% over a decade. Joel Greenblatt might see a standout compounder of earnings.
172.98%
5Y net income/share CAGR > 1.5x Insurance - Life median of 22.52%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
110.11%
3Y net income/share CAGR > 1.5x Insurance - Life median of 30.35%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
80.48%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
55.97%
5Y equity/share CAGR > 1.5x Insurance - Life median of 33.61%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
17.69%
3Y equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai credits disciplined capital allocation for short-term outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.60%
AR growth of 17.60% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
3.95%
Asset growth near Insurance - Life median. Charlie Munger attributes it to a typical industry cycle of capital investment.
3.91%
75-90% of Insurance - Life median. John Neff calls for higher ROE or more effective capital usage to match peers.
-4.77%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-17.27%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.